Inspire Medical Systems, Inc. (NYSE: INSP) was upgraded by analysts at Bank of America Co. from a "neutral" rating to a "buy" rating. They now have a $255.00 price target on the stock, up previously from $220.00.
LowReport
Inspire Medical Systems, Inc. (NYSE: INSP) was upgraded by analysts at Bank of America Co. from a "neutral" rating to a "buy" rating. They now have a $255.00 price target on the stock, up previously from $220.00.
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Don’t Miss Out On The Next BIG Stock Move
"Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ blog email newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our blog below: